Denna vill vi hålla koll på:This multi-center, randomized, double-blind, placebo-controlled study, conducted in Turkey, will assess the efficacy and safety of topical SM04554 solution (0.15% and 0.25%) applied daily to the scalp of male androgenetic alopecia (AGA) subjects.
https://clinicaltrials.gov/ct2/show/NCT ... rm=samumed